JP Patent

JP5926756B2 — ルリコナゾールを含有する製剤の評価方法及び指標物質

Assigned to Pola Pharma Inc · Expires 2016-05-25 · 10y expired

What this patent protects

Patent listed against Luzu.

Drugs covered by this patent

Patent Metadata

Patent number
JP5926756B2
Jurisdiction
JP
Classification
—
Expires
2016-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Pola Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.